139 related articles for article (PubMed ID: 26695739)
1. Comparison of survival of adolescents and young adults with hematologic malignancies in Osaka, Japan.
Nakata-Yamada K; Inoue M; Ioka A; Ito Y; Tabuchi T; Miyashiro I; Masaie H; Ishikawa J; Hino M; Tsukuma H;
Leuk Lymphoma; 2016; 57(6):1342-8. PubMed ID: 26695739
[TBL] [Abstract][Full Text] [Related]
2. Trends in survival of leukemia among children, adolescents, and young adults: A population-based study in Osaka, Japan.
Nakata K; Okawa S; Fuji S; Sato A; Morishima T; Tada Y; Inoue M; Hara J; Kawa K; Miyashiro I;
Cancer Sci; 2021 Mar; 112(3):1150-1160. PubMed ID: 33428808
[TBL] [Abstract][Full Text] [Related]
3. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
4. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
Wolfson J; Sun CL; Wyatt L; Stock W; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):312-320. PubMed ID: 28209594
[No Abstract] [Full Text] [Related]
5. Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.
Horibe K; Saito AM; Takimoto T; Tsuchida M; Manabe A; Shima M; Ohara A; Mizutani S
Int J Hematol; 2013 Jul; 98(1):74-88. PubMed ID: 23702913
[TBL] [Abstract][Full Text] [Related]
6. Survival analysis after diagnosis with malignancy of Egyptian adolescent patients: a single-center experience.
Tantawy AA; El Sherif NH; Ebeid FS; El-Desouky ED
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e346-52. PubMed ID: 24517961
[TBL] [Abstract][Full Text] [Related]
7. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
Pulte D; Gondos A; Brenner H
Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic approaches to hematological malignancies in adolescents and young adults].
Sekimizu M
Rinsho Ketsueki; 2018; 59(10):2273-2283. PubMed ID: 30305536
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
10. Pattern of hematological malignancies in adolescents and young adults in Bangladesh.
Hasan MM; Raheem E; Sultana TA; Hossain MS
Cancer Epidemiol; 2017 Dec; 51():109-112. PubMed ID: 29121606
[TBL] [Abstract][Full Text] [Related]
11. Survival From Childhood Hematological Malignancies in Denmark: Is Survival Related to Family Characteristics?
Erdmann F; Winther JF; Dalton SO; Lightfoot T; Zeeb H; Simony SB; Deltour I; Ferro G; Bautz A; Schmiegelow K; Schüz J
Pediatr Blood Cancer; 2016 Jun; 63(6):1096-104. PubMed ID: 26937602
[TBL] [Abstract][Full Text] [Related]
12. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
13. Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan.
Hagiwara S; Yotsumoto M; Odawara T; Ajisawa A; Uehira T; Nagai H; Tanuma J; Okada S
AIDS; 2013 Jan; 27(2):279-83. PubMed ID: 23014520
[TBL] [Abstract][Full Text] [Related]
14. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.
Trama A; Botta L; Foschi R; Ferrari A; Stiller C; Desandes E; Maule MM; Merletti F; Gatta G;
Lancet Oncol; 2016 Jul; 17(7):896-906. PubMed ID: 27237614
[TBL] [Abstract][Full Text] [Related]
15. Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States.
Blum KA; Keller FG; Castellino S; Phan A; Flowers CR
Br J Haematol; 2018 Nov; 183(3):385-399. PubMed ID: 30095154
[TBL] [Abstract][Full Text] [Related]
16. Survival from haematological malignancy in childhood, adolescence and young adulthood in Australia: is the age-related gap narrowing?
Pinkerton R; Wills RA; Coory MD; Fraser CJ
Med J Aust; 2010 Aug; 193(4):217-21. PubMed ID: 20712542
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
[TBL] [Abstract][Full Text] [Related]
18. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.
Elidrissi Errahhali M; Elidrissi Errahhali M; Boulouiz R; Ouarzane M; Bellaoui M
BMC Cancer; 2016 Feb; 16():159. PubMed ID: 26915519
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults.
Keegan TH; Ries LA; Barr RD; Geiger AM; Dahlke DV; Pollock BH; Bleyer WA;
Cancer; 2016 Apr; 122(7):1009-16. PubMed ID: 26848927
[TBL] [Abstract][Full Text] [Related]
20. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
